Literature DB >> 9677574

[Serous central chorioretinopathy and endogenous hypercortisolemia].

A D Kapetanios1, G Donati, E Bouzas, G Mastorakos, C J Pournaras.   

Abstract

BACKGROUND: The exact pathogenic mechanism of the accumulation of subretinal fluid at the posterior pole of the fundus in cases of central serous chorioretinopathy (CSC) is not well established. Recently, it was reported that CSC is more frequent among patients with endogenous Cushing's syndrome. Thus, it has been suggested that glucocorticoids might be involved in the pathogenesis of CSC. Subsequently, additional observations, have confirmed the relationship between glucocorticoids and CSC. We present preliminary data on the endogenous cortisol secretion in patients with CSC. PATIENTS AND
METHOD: Sixteen patients (14 men and 2 women, 35-65 years of age) suffering from CSC, not exposed to exogenous glucocorticoids and without clinical and/or biological stigmata of endogenous Cushing's syndrome, have been examined. Twenty four hour urinary free cortisol (24 h-UFC) secretion was measured within one week of their CSC episode. Twenty four hour urinary free cortisol of age and sex matched controls were also measured.
RESULTS: Twenty four hour urinary free cortisol was 188.20 nmol/l +/- 34.1 for the patients suffering from CSC and 115.3 nmol/l +/- 63.4 for the control group (p < 0.05).
CONCLUSION: These results give additional evidence that glucocorticoids may play a role in the pathogenesis of CSC. However, given the substantial variability of urinary free cortisol levels, as indicated by the increased SD, additional number of patients should be examined.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9677574     DOI: 10.1055/s-2008-1034901

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  7 in total

1.  The relation of somatotypes and stress response to central serous chorioretinopathy.

Authors:  Roy Schwartz; Assaf Rozenberg; Anat Loewenstein; Michaella Goldstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-09-05       Impact factor: 3.117

2.  Serum cortisol and testosterone levels in chronic central serous chorioretinopathy.

Authors:  Hasan Ali Tufan; Baran Gencer; Arzu Taskiran Comez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-06-21       Impact factor: 3.117

3.  Central Serous Chorioretinopathy after Rhinoplasty.

Authors:  Marilita M Moschos; Konstantinos Droutsas; Ioannis Margetis
Journal:  Case Rep Ophthalmol       Date:  2010-11-06

4.  Comparison of Serum Cortisol and Testosterone Levels in Acute and Chronic Central Serous Chorioretinopathy.

Authors:  Tanie Natung; Avonuo Keditsu
Journal:  Korean J Ophthalmol       Date:  2015-11-25

5.  Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy.

Authors:  Shaik M Zakir; M Shukla; Zaka-Ur-Rab Simi; J Ahmad; Mahmood Sajid
Journal:  Indian J Ophthalmol       Date:  2009 Nov-Dec       Impact factor: 1.848

Review 6.  Gonadal Hormones and Retinal Disorders: A Review.

Authors:  Raffaele Nuzzi; Simona Scalabrin; Alice Becco; Giancarlo Panzica
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-02       Impact factor: 5.555

7.  Cushing's Syndrome and Hypothalamic-Pituitary-Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy.

Authors:  Femke M van Haalen; Elon H C van Dijk; Olaf M Dekkers; Maurice B Bizino; Greet Dijkman; Nienke R Biermasz; Camiel J F Boon; Alberto M Pereira
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-20       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.